News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy
Miguel Lopez de Rodas Gregorio/medicine.yale.edu
Jan 21, 2025, 06:22

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy

A recent paper by Miguel Lopez de Rodas, Associate Research Scientist in Pathology at Yale Cancer Center, was mentioned by Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, on X

“Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach”

Authors: Miguel Lopez de Rodas, Maria Villalba-Esparza, Miguel Sanmamed, Lieping Chen, David Rimm and Kurt Schalper.

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy

“Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.

Biological properties and biomarker potential for ICI therapy.”

More posts featuring Hidehito Horinouchi.

cancer David Rimm Hidehito Horinouchi Kurt Schalper Lieping Chen Maria Villalba-Esparza Miguel Lopez de Rodas Miguel Sanmamed OncoDaily Oncology
Special Coverage
Insight
Jan 21, 2025, 06:22
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy
Insight
Jan 21, 2025, 06:17
Fabio Moraes: Global linear accelerator requirements and personalised country recommendations
Blog
Jan 21, 2025, 06:15
Petros Grivas: Excited for our 12th Immune-related Adverse Events panel CME series
Blog
Jan 21, 2025, 05:44
Aruni Ghose: Collaboration with Dr. Swarupa Mitra on innovative cancer care
Blog
Jan 21, 2025, 05:12
Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ
Blog
Jan 21, 2025, 05:10
Mark Lawler: The severe cancer workforce crisis - a ticking time bomb that must be diffused to avert a cancer crisis
Blog
Jan 21, 2025, 04:58
The 2025 American Cancer Society Cancer Statistics report
Blog
Jan 21, 2025, 04:55
ASCO applauds Dr. Monica M. Bertagnolli and Dr. Kimryn Rathmell for their exceptional leadership and dedication at NIH and NCI
Blog
Jan 21, 2025, 04:17
Amil Družić: HPV Doesn’t Choose – Get Informed, Protect Yourself, Prevent!
Blog
Jan 20, 2025, 20:33
Jame Abraham: Proud to be part of Top Accruing LAPS NRG oncology trials
Blog
Jan 20, 2025, 20:31
Health in the age of disinformation - The Lancet
Blog
Jan 20, 2025, 20:29
Shilpa Gupta: Improving the lives of patients with bladder cancer with a multi-disciplinary and personalized approach